STOCK TITAN

Arcellx (NASDAQ: ACLX) — T. Rowe Price reports 4.5% holding in 13G/A

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Arcellx Inc. Schedule 13G/A discloses that T. Rowe Price Investment Management, Inc. beneficially owned 2,653,848 shares of Arcellx common stock, representing 4.5% of the class as of 02/28/2026. The filing states sole voting power of 2,503,059 shares and sole dispositive power of 2,647,494. Item 5 notes ownership of 5 percent or less of a class.

Positive

  • None.

Negative

  • None.





02/28/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Investment Management, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:03/06/2026

FAQ

What did T. Rowe Price report for ACLX in the Schedule 13G/A?

Direct answer: T. Rowe Price reported beneficial ownership of 2,653,848 shares (4.5%) of Arcellx common stock as of 02/28/2026. Context: The filing lists sole voting power of 2,503,059 and sole dispositive power of 2,647,494.

Does the filing indicate T. Rowe Price controls more than 5% of ACLX?

Direct answer: No, the filing indicates ownership of 4.5%, which is under 5 percent. Context: Item 5 expressly states "Ownership of 5 percent or less of a class," and the cover shows the 4.5% figure.

What powers over the shares does T. Rowe Price report for ACLX?

Direct answer: The filer reports sole voting power for 2,503,059 shares and sole dispositive power for 2,647,494 shares. Context: The filing shows no shared voting or dispositive power for these holdings.

What date is the ownership in the ACLX Schedule 13G/A measured as of?

Direct answer: The filing lists the measurement date as 02/28/2026. Context: The amendment header shows that date and the signature block is dated 03/06/2026, consistent with the Schedule 13G/A amendment timing.

Does the Schedule 13G/A imply beneficial ownership by an individual at T. Rowe Price?

Direct answer: No, the filer is listed as T. Rowe Price Investment Management, Inc., a Maryland entity, not an individual. Context: The filing includes a corporate signature by a Vice President, and it disclaims admission of beneficial ownership in the text.
ARCELLX INC

NASDAQ:ACLX

ACLX Rankings

ACLX Latest News

ACLX Latest SEC Filings

ACLX Stock Data

6.69B
48.51M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
REDWOOD CITY